A Study of Baricitinib and Birth Control Pills in Healthy Females

Summary

The main purpose of this study is to find out how the body absorbs and breaks down a common birth control pill called Microgynon when it is given with the study drug called baricitinib. Safety and the body's ability to tolerate baricitinib and Microgynon will also be studied. The study will last approximately 6 weeks for each participant.

Timeline

Start

2013-07

Primary completion

2013-10

Completion

2013-10

Drugs

Indications

No indication recorded.